Skip to main content

Table 2 Efficacies of induction therapy in 20 previously reported patients with anti-GAD antibodies associated cerebellar ataxia. Data based on short-term follow-up

From: Guidelines for treatment of immune-mediated cerebellar ataxias

 

High responders

Low responders

No change

Sum

Subacute type

    

mPSL

2

0

0

2

IVIg + PE

0

0

1

1

IVIg + R

1

0

0

1

PE + R

1

0

1

2

Sum

4

0

2

6

Chronic type

    

mPSL

2

1

2

5

mPSL + IVIg

0

1

0

1

mPSL + PE

1

1

0

2

oral PSL

0

1

0

1

IVIg

3

1

2

6

IVIg + R

0

1

1

2

PE

2

0

0

2

Sum

8

6

5

19a

  1. aSince two of 14 patients were repeatedly treated due to relapse, the number of therapies was 19.
  2. mPSL intravenous methylprednisolone, oral PSL oral prednisolone, IVIg intravenous immunoglobulins, PE plasma exchange, R rituximab